Occudo Quantitative Strategies LP Aclaris Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.64 - $6.49 $8,642 - $87,640	13,504 New	13,504 $14,000
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $335 - $563	33 Added 0.28%	11,799 $165,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $91,331 - $168,035	-9,377 Reduced 44.35%	11,766 $203,000
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $75,730 - $114,120	-6,172 Reduced 22.6%	21,143 $307,000
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $92,977 - $130,641	6,949 Added 34.12%	27,315 $492,000
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $125,076 - $216,760	7,323 Added 56.15%	20,366 $358,000
Q1 2021 May 14, 2021	BUY	$5.86 - $27.73 $76,431 - $361,682	13,043 New	13,043 $329,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.